On April 6^th, US-based biopharmaceutical company Cephalon, Inc. (NASDAQ: CEPH) acquired all of the outstanding capital stock of Ception Therapeutics, Inc., also a US-based biopharmaceutical company focused on developing novel products to address areas of unmet medical …

Continue Reading Biopharmaceutical Companies Cephalon and Ception Merge; Choice in Investment Bank One Key Component of Deal Success